Éric Rouvier
Impact in
- Immunology top 1%
- T-cell and B-cell Immunology
- Psoriasis: Treatment and Pathogenesis
- Rheumatology top 2%
- Rheumatoid Arthritis Research and Therapies
Papers in
-
- Radiopharmaceutical Chemistry and Applications 16
- Monoclonal and Polyclonal Antibodies Research 1
-
- T-cell and B-cell Immunology 6
- Immunotherapy and Immune Responses 1
- Co-authors
- Pierre Golstein (5 shared papers)Marie‐Françoise Luciani (4 shared papers)Marie‐Geneviève Mattéi (2 shared papers)François Denizot (1 shared paper)Odile Djossou (1 shared paper)Smina Aït‐Yahia (1 shared paper)François Fossiez (1 shared paper)Sem Saeland (1 shared paper)
- Journals
- International Journal of Cancer (3 papers)The Journal of Immunology (2 papers)The Journal of Experimental Medicine (2 papers)Oncogene (1 paper)Lung Cancer (1 paper)
- Partner nations
- FranceSwitzerland
In The Last Decade
Éric Rouvier
23 papers receiving 3.6k citations
Éric Rouvier's Hit Papers
Peers
Comparison fields: 5 of 87
- Immunology 1.3k
- Rheumatology 381
- Radiology, Nuclear Medicine and Imaging 545
- Oncology 471
- Molecular Biology 562
Countries citing papers authored by Éric Rouvier
This map shows the geographic impact of Éric Rouvier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Rouvier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Rouvier more than expected).
Fields of papers citing papers by Éric Rouvier
This network shows the impact of papers produced by Éric Rouvier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Rouvier. The network helps show where Éric Rouvier may publish in the future.
Co-authors
The 25 scholars most cited alongside Éric Rouvier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. Hit paper breakdown → | 1996 | 1301 |
| 2 | Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity. Hit paper breakdown → | 1993 | 726 |
| 3 | 1993 | 659 | |
| 4 | 1991 | 375 | |
| 5 | Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody. | 1998 | 92 |
| 6 | Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: preliminary results of a phase I/II clinical trial. | 1999 | 88 |
| 7 | 1999 | 80 | |
| 8 | 2001 | 71 | |
| 9 | Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and 131I-labeled bivalent hapten. | 2000 | 67 |
| 10 | Bispecific antibody and iodine-131-labeled bivalent hapten dosimetry in patients with medullary thyroid or small-cell lung cancer. | 1996 | 49 |
| 11 | Radioimmunotherapy of small cell lung carcinoma with the two-step method using a bispecific anti-carcinoembryonic antigen/anti-diethylenetriaminepentaacetic acid (DTPA) antibody and iodine-131 Di-DTPA hapten: results of a phase I/II trial. | 1999 | 46 |
| 12 | Delivery of therapeutic doses of radioiodine using bispecific antibody-targeted bivalent haptens. | 1998 | 42 |
| 13 | CTLA-4 and CD28: similar proteins, neighbouring genes. | 1992 | 35 |
| 14 | 1997 | 29 | |
| 15 | 1994 | 26 | |
| 16 | Two-step immunoscintigraphy for non-small-cell lung cancer staging using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer. | 1997 | 24 |
| 17 | Successful surgical removal of occult metastases of medullary thyroid carcinoma recurrences with the help of immunoscintigraphy and radioimmunoguided surgery. | 2000 | 21 |
| 18 | 1996 | 13 | |
| 19 | 1997 | 8 | |
| 20 | 1995 | 7 |
About Éric Rouvier
Éric Rouvier is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Endocrinology, Diabetes and Metabolism, Oncology and Molecular Biology, having authored 24 papers that have together received 3.8k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (16 papers), T-cell and B-cell Immunology (6 papers), Thyroid Cancer Diagnosis and Treatment (4 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Cell death mechanisms and regulation (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Immunology (1.3k citations), Rheumatology (381 citations), Radiology, Nuclear Medicine and Imaging (545 citations), Oncology (471 citations) and Molecular Biology (562 citations). Éric Rouvier has collaborated with scholars based in France and Switzerland. Frequent co-authors include Pierre Golstein, Marie‐Françoise Luciani, Marie‐Geneviève Mattéi, François Denizot, Odile Djossou, Smina Aït‐Yahia, François Fossiez, Sem Saeland, Serge Lebecque and Jacques Banchereau. Their work appears in journals such as International Journal of Cancer, The Journal of Immunology, The Journal of Experimental Medicine, Oncogene and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.